Articles by Date (Latest First)
Filter by author: Aly | Sam | Lain | Mitzi
A Review of Pharmaceutical Interventions for Scalp Hair Loss and Implications for Transfeminine People (Sam, September 2025)
Puberty Blockers: A Review of GnRH Analogues in Transgender Youth (Mitzi, January 2022)
An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters (Aly, July 2021)
An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations (Aly, July 2021)
An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People (Sam, June 2021)
Clinical Guidelines with Information on Transfeminine Hormone Therapy (Aly, November 2020)
Spironolactone and Claims About Increased Visceral Fat in Transfeminine People (Aly, October 2020)
Estrogens and Their Influences on Coagulation and Risk of Blood Clots (Aly, October 2020)
The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy (Aly, July 2020)
Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy (Aly, July 2020)
Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy (Aly, July 2020)
On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy (Lain, May 2020)
Hormone Levels During Normal Puberty in Cisgender Girls (Aly, April 2020)
Breast Cancer Risk with Hormone Therapy in Transfeminine People (Aly, April 2020)
The Possible Role of a Second X Chromosome in Breast Cancer Risk (Aly, April 2020)
Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People (Aly, April 2020)
Approximate Comparable Dosages of Estradiol by Different Routes (Aly, April 2020)
Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy (Sam, April 2020)
A Comparison of Oral and Transdermal Estradiol in Transfeminine Hormone Therapy (Sam, April 2020)
Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes (Sam, April 2020)
Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer (Sam, April 2020)
Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People (Aly, March 2020)
Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk (Sam, February 2020)
A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People (Aly, February 2020)
The Influence of Progesterone and Other Progestogens on Sexual Desire and Function (Aly, January 2020)
A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy (Lain, October 2019)
Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy (Lain, October 2019)
Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy (Lain, September 2019)
On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy (Lain, September 2019)
The Relationship Between the Endocrine System and Muscle Mass (Lain, August 2019)
Literature on Early Progestogen Exposure and Breast Development (Aly, July 2019)
Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People (Aly, July 2019)
Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work (Aly, June 2019)
An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People (Aly, June 2019)
Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People (Aly, March 2019)
Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018) (Aly, March 2019)
Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People (Aly, March 2019)
Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People (Aly, January 2019)
A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People (Aly, December 2018)
Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies (Aly, August 2018)
Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects (Aly, August 2018)
Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects (Aly, August 2018)
An Introduction to Hormone Therapy for Transfeminine People (Aly, August 2018)
EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future (Aly, August 2018)